Ivermectin
Overview
Ivermectin is an antiparasitic agent used to treat several parasitic infestations. It works by binding to glutamate-gated chloride channels, causing paralysis and death of the parasite.
API suppliers (6)
Suppliers of Ivermectin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 6 suppliers.
1 of 6 holds a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance
- HOVIONE PHARMASCIENCE LTDMacau1 active DMF
- Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- HEBEI MEIHE PHARMACEUTICAL CO LTD1 active DMF
- DELTA TECH LTD
- Pharmascience Inc.CanadaCEP
- SHANGHAI TONGREN PHARMACEUTICAL CO LTD
Patent & exclusivity (US)
Per the FDA Orange Book (15 approved US products), the latest listed US patent on Ivermectin expires 13 Mar 2034. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Ivermectin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.